CHI3L3+ immature neutrophils inhibit anti-tumor immunity and impede immune checkpoint blockade therapy in bone metastases
Cancer Cell · 2025-10 · 43 (10) · 1937-1957.e11
DOI: 10.1016/j.ccell.2025.07.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2025-10. Verfasst von Tao Shi und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China; State Key Laboratory …. Hauptthemen laut MEDLINE: Neutrophils, Bone Neoplasms, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: Swim Across America, Fundamental Research Funds for the Central Universities, Key Technologies Research and Development Program.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing Univ…
- National Resource Center for Mutant Mice and MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, School of Medicine, Nanjing University, Nanjing, China.
- Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Department of Pathology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Swim Across America and Ludwig Collaborative Laboratory, Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA; Parker Institute for Cancer Immunotherapy and Sandra and Edward Meyer Cancer Center at Weil…
- Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Jiangsu University, Nanjing, China.
Förderung
- Swim Across America
- Fundamental Research Funds for the Central Universities
- Key Technologies Research and Development Program
- Bristol-Myers Squibb
- Pfizer
- Shenzhen Bay Laboratory
- Ludwig Institute for Cancer Research
- Parker Institute for Cancer Immunotherapy
Zitieren
APA
Shi, T., Liu, W., Luo, Y., Liang, K., Ren, S., Song, X., Liu, F., Lu, C., Hirschhorn, D., Wang, H., Zhang, Y., Cai, Y., Wang, Y., Pan, Y., Liu, W., Nie, Y., Zhang, Z., Yu, L., Ding, S., …, & Wei, J. (2025). CHI3L3+ immature neutrophils inhibit anti-tumor immunity and impede immune checkpoint blockade therapy in bone metastases. Cancer Cell, 43(10), 1937-1957.e11. https://doi.org/10.1016/j.ccell.2025.07.007
Vancouver
Shi T, Liu W, Luo Y, Liang K, Ren S, Song X, et al. CHI3L3+ immature neutrophils inhibit anti-tumor immunity and impede immune checkpoint blockade therapy in bone metastases. Cancer Cell. 2025;43(10):1937-1957.e11. doi:10.1016/j.ccell.2025.07.007
BibTeX
@article{Shi2025,
author = {Shi, Tao and Liu, Wei and Luo, Yuting and Liang, Kaijie and Ren, Shiji and Song, Xueru and Liu, Fangcen and Lu, Chun and Hirschhorn, Daniel and Wang, Hanbing and Zhang, Yipeng and Cai, Yiran and Wang, Yue and Pan, Yunfeng and Liu, Wenqi and Nie, Yang and Zhang, Ziliang and Yu, Lixia and Ding, Shuai and Liu, Baorui and Merghoub, Taha and Li, Yan and Wei, Jia},
title = {CHI3L3+ immature neutrophils inhibit anti-tumor immunity and impede immune checkpoint blockade therapy in bone metastases},
journal = {Cancer Cell},
year = {2025},
volume = {43},
number = {10},
pages = {1937--1957.e11},
doi = {10.1016/j.ccell.2025.07.007}
}
EUVIMED